Skip to content
PICO Portalanswers from OpenAlex

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors

PaperCitations, authors & open-access status

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors is a paper indexed in PICO Portal from OpenAlex.

How many citations does Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors have?

PICO Portalcitation count

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors has 29 citations in the OpenAlex counts PICO Portal stores.

When was Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors published?

PICO Portalyear

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors has 2023 year in the PICO Portal index.

What is the open-access status of Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors?

PICO Portaloa status

Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors has gold oa status in the PICO Portal index.

What is the DOI of Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors?

PICO Portaldoi

The DOI for Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors is on the source record.

What is the PMID of Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors?

PICO Portalpmid

The PMID for Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors is on the source record.

What is the OpenAlex record for Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors?

PICO Portalopenalex

The OpenAlex for Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial